| Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson disease S Hunot, B Brugg, D Ricard, PP Michel, MP Muriel, M Ruberg, ... Proceedings of the National Academy of Sciences 94 (14), 7531-7536, 1997 | 887 | 1997 |
| Primary brain tumours in adults D Ricard, A Idbaih, F Ducray, M Lahutte, K Hoang-Xuan, JY Delattre The Lancet 379 (9830), 1984-1996, 2012 | 734 | 2012 |
| CNS complications of radiotherapy and chemotherapy C Soussain, D Ricard, JR Fike, JJ Mazeron, D Psimaras, JY Delattre The lancet 374 (9701), 1639-1651, 2009 | 468 | 2009 |
| The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings G Cavaletti, DR Cornblath, ISJ Merkies, TJ Postma, E Rossi, B Frigeni, ... Annals of Oncology 24 (2), 454-462, 2013 | 362 | 2013 |
| Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies J Honnorat, S Cartalat-Carel, D Ricard, JP Camdessanche, AF Carpentier, ... Journal of Neurology, Neurosurgery & Psychiatry 80 (4), 412-416, 2009 | 284 | 2009 |
| Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A factor in extracellular vesicles L Treps, R Perret, S Edmond, D Ricard, J Gavard Journal of extracellular vesicles 6 (1), 1359479, 2017 | 274 | 2017 |
| Radiotherapy or autologous stem-cell transplantation for primary CNS lymphoma in patients 60 years of age and younger: results of the intergroup ANOCEF-GOELAMS randomized phase … C Houillier, L Taillandier, S Dureau, T Lamy, M Laadhari, O Chinot, ... Journal of clinical oncology 37 (10), 823-833, 2019 | 247 | 2019 |
| Dynamic history of low‐grade gliomas before and after temozolomide treatment D Ricard, G Kaloshi, A Amiel‐Benouaich, J Lejeune, Y Marie, ... Annals of Neurology: Official Journal of the American Neurological …, 2007 | 234 | 2007 |
| A review of center of pressure (COP) variables to quantify standing balance in elderly people: Algorithms and open‐access code F Quijoux, A Nicolaï, I Chairi, I Bargiotas, D Ricard, A Yelnik, L Oudre, ... Physiological reports 9 (22), e15067, 2021 | 212 | 2021 |
| Neurological toxicities associated with immune-checkpoint inhibitors M Touat, D Talmasov, D Ricard, D Psimaras Current opinion in neurology 30 (6), 659-668, 2017 | 210 | 2017 |
| Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin P Alberti, E Rossi, DR Cornblath, ISJ Merkies, TJ Postma, B Frigeni, ... Annals of oncology 25 (1), 257-264, 2014 | 192 | 2014 |
| A tumor growth inhibition model for low-grade glioma treated with chemotherapy or radiotherapy B Ribba, G Kaloshi, M Peyre, D Ricard, V Calvez, M Tod, ... Clinical Cancer Research 18 (18), 5071-5080, 2012 | 187 | 2012 |
| Inertial sensors to assess gait quality in patients with neurological disorders: a systematic review of technical and analytical challenges A Vienne, RP Barrois, S Buffat, D Ricard, PP Vidal Frontiers in psychology 8, 817, 2017 | 172 | 2017 |
| Primary CNS lymphoma in immunocompetent patients M Sierra del Rio, A Rousseau, C Soussain, D Ricard, K Hoang-Xuan The oncologist 14 (5), 526-539, 2009 | 167 | 2009 |
| Phase II study of radiotherapy and temsirolimus versus radiochemotherapy with temozolomide in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation … W Wick, T Gorlia, P Bady, M Platten, MJ Van Den Bent, MJB Taphoorn, ... Clinical cancer research 22 (19), 4797-4806, 2016 | 157 | 2016 |
| Isolation and expression pattern of human Unc-33-like phosphoprotein 6/collapsin response mediator protein 5 (Ulip6/CRMP5): coexistence with Ulip2/CRMP2 in Sema3a-sensitive … D Ricard, V Rogemond, E Charrier, M Aguera, D Bagnard, MF Belin, ... Journal of Neuroscience 21 (18), 7203-7214, 2001 | 148 | 2001 |
| Extracellular vesicle-transported Semaphorin3A promotes vascular permeability in glioblastoma L Treps, S Edmond, E Harford-Wright, EM Galan-Moya, A Schmitt, S Azzi, ... Oncogene 35 (20), 2615-2623, 2016 | 132 | 2016 |
| Environmental risk factors of primary brain tumors: A review A Vienne-Jumeau, C Tafani, D Ricard Revue neurologique 175 (10), 664-678, 2019 | 124 | 2019 |
| Center of pressure displacement characteristics differentiate fall risk in older people: A systematic review with meta-analysis F Quijoux, A Vienne-Jumeau, F Bertin-Hugault, P Zawieja, M Lefevre, ... Ageing Research Reviews 62, 101117, 2020 | 105 | 2020 |
| Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas M Peyre, S Cartalat-Carel, D Meyronet, D Ricard, A Jouvet, J Pallud, ... Neuro-oncology 12 (10), 1078-1082, 2010 | 103 | 2010 |
Pierre-Paul VIDALCNRSVerified email at parisdescartes.fr